Compare TOON & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOON | XLO |
|---|---|---|
| Founded | 2006 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 41.8M |
| IPO Year | N/A | 2021 |
| Metric | TOON | XLO |
|---|---|---|
| Price | $0.75 | $0.74 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 265.5K | ★ 655.2K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,081,000.00 | $31,804,000.00 |
| Revenue This Year | N/A | $589.60 |
| Revenue Next Year | N/A | $38.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 22.21 | ★ 588.40 |
| 52 Week Low | $0.46 | $0.62 |
| 52 Week High | $0.93 | $1.70 |
| Indicator | TOON | XLO |
|---|---|---|
| Relative Strength Index (RSI) | 56.37 | 46.59 |
| Support Level | $0.71 | $0.69 |
| Resistance Level | $0.77 | $0.76 |
| Average True Range (ATR) | 0.05 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 88.26 | 54.49 |
Kartoon Studios Inc is a media company developing, producing, marketing, and licensing branded animated entertainment properties and consumer products for media and retail distribution. Its portfolio features programming for toddlers to tweens, including the preschool properties Rainbow Rangers for Nick Jr. and Llama Llama for Netflix, Stan Lee's Superhero Kindergarten, Shaq's Garage, toddler brand Baby Genius, STEM-based series Thomas Edison's Secret Lab, Warren Buffett's Secret Millionaires Club, and the new preschool show, Stan Lee's Superhero Kindergarten. Its channel is available on television and mobile devices through distribution platforms, including Comcast, Cox, DISH, Sling TV, Apple TV, Roku, Android TV, Tubi, Xumo, and Amazon Fire.
Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.